• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Intel, Samsung Partner on AI-Based Ultrasound Solution for Anesthesia Administration

by Fred Pennic 03/16/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Intel, Samsung Partner on AI-Based Ultrasound Solution for Anesthesia Administration

What You Should Know:

–  Samsung Medison and Intel are collaborating on NerveTrack™, a real-time nerve tracking ultrasound feature that helps anesthesiologists identify nerves in a patient’s arm to help administer anesthesia quickly and accurately. Leveraging the Intel Distribution of OpenVINO toolkit for computer vision and annotation, Samsung Medison’s NerveTrack™ can reduce scanning time by up to 30 percent in an extremely difficult case.[1]

– Ultrasound-guided regional anesthesia (UGRA) is becoming standard practice for needle-based interventions, including vascular access and peripheral nerve block. However, even with UGRA, it can be difficult for anesthesiologists to correctly identify nerves, which can be as small as 2 millimeters in diameter, or to see the needle tip properly. NerveTrack™, can automatically identify nerves in real time for anesthesiologists — reducing the possibility of complications while improving workflows.

– NerveTrack™ was developed based on Intel’s OpenVINO toolkit. It uses inference to detect and identify the location of a nerve area in real time during an ultrasound scan, improving the treatment workflow for anesthesiologists. To train Samsung’s proprietary real-time algorithm that automatically detects nerves in ultrasound images, a significant amount of clinical ultrasound data was required. And with Intel’s OpenVINO CVAT (Computer Vision Annotation Tool), the total volume of training data increased up to 7x, leading to improved accuracy of more than 20 percent.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, intel, Samsung, Ultrasound

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |